TTS 2026 Program

Corporate Symposia

Sunday, September 20

13:30–14:30
Room C3.4–C3.5 · Program #101
Industry Symposium

Sobi Symposium - Treat the cause, not the consequences: Updates in the management of C3G & primary IC-MPGN

Supported by
Sobi

Monday, September 21

08:00–09:00
Parkside 1&2 · Program #200
Industry Symposium

Takeda Corporate Breakfast Symposium on Illuminated Constellations: How Diverse Institutional Experiences Guide Practical CMV Management

Supported by
Takeda
12:15–13:15
Parkside 1&2 · Program #250
Industry Symposium

Hansa BioPharma Corporate Lunch Symposium on Transplanting the untransplantable – Idefirix® (imlifidase), a breakthrough innovation for highly sensitised kidney transplantation

Supported by
Hansa BioPharma
17:00–17:45
Cockle Bay 2 · Program #298
Industry Symposium

Expanding the living donor pool in kidney transplantation: Insights from Indian experience

Supported by an educational grant from
Zydus

Tuesday, September 22

07:00–08:00
Parkside 1&2 · Program #300
Industry Symposium

Bridge to Life Corporate Breakfast Symposium on Scaling better outcomes: The role of HOPE in contemporary transplant programs

Supported by
Bridge to Life
12:15–13:15
Parkside 1&2 · Program #350
Industry Symposium

Astellas Corporate Lunch Symposium on Strengthening the foundation: How consistent management drives durable graft health

Organized by
Astellas
17:00–18:00
Room C3.3 · Program #398
Industry Symposium

Corporate Symposium on State-of-the-Art Care for Kidney Transplant Recipients: Implications for the Forthcoming KDIGO Guideline Update

Supported by an independent educational grant from
Veloxis Pharmaceuticals

Wednesday, September 23

07:00–08:00
Parkside 1&2 · Program #400
Industry Symposium

Biogen Corporate Breakfast Symposium on Microvascular inflammation: A defining characteristic of antibody mediated rejection in kidney transplantation

Supported by
Biogen
Loading...
Loading...